Neurosurgery Perioperative Orders & Functional Case Checklist
A medical-student orientation guide to common post-op neurosurgery workflows, ICU/TBI checklists, and functional neurosurgery handoffs.
1. Post-Op Craniotomy
Use immediately after craniotomy, burr hole, CSF shunt, or stereotactic procedures. Most components default-on; titrate vitals/neuro-check frequency to acuity.
Patient Care / Monitoring
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Vital Signs | Routine | Q15min × 1 hr → Q30min × 1 hr → Q1H |
| Vital Signs (after +2 hr) | Q1H | Transition order |
| Neuro Checks | Q15min × 1 hr → Q30min × 1 hr → Q1H | Mirror VS cadence |
| Neuro Checks (after +2 hr) | Q1H | |
| Check Procedural Site | Q15min × 1 hr → Q30min × 1 hr → Q1H × 4 hr → Q4H | Surgical wound / drain site |
| Height & Weight | ONCE | For weight-based dosing |
| Convert IV to saline lock | ONCE | When tolerating PO |
| Urinary Catheter | Indwelling | Remove POD#1 AM if possible |
| Intake & Output | Q1H | |
| D/C Urinary Catheter | ONCE — AM POD#1 | SCIP / CAUTI prevention |
| Nurse Communication | — | Do not remove urinary catheter if UOP <30 mL/hr |
| Dysphagia Screen | ONCE | Before any PO |
| Notify Provider of UOP | — | If UOP >250 mL/hr × 3 consecutive hours (DI surveillance) |
Activity / Positioning
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Activity | Bed rest | Advance per surgeon |
| Position Patient | Constant | HOB elevated 30° |
| Turn & Reposition | Q2H | Pressure injury prevention |
Diet / IV Fluids
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| NPO | — | NPO except for medications until cleared |
| Diet | Regular (when cleared) | Advance after dysphagia screen |
| 0.9% NaCl | 1,000 mL IV @ 80 mL/hr | Default maintenance — avoid hypotonic in TBI |
| Lactated Ringers | 1,000 mL IV @ 80 mL/hr | Alternative isotonic |
Medications — Symptomatic
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Acetaminophen | 650 mg PO Q4H PRN | Fever >38.4 °C / mild pain / HA |
| Ondansetron | 4 mg IV push Q6H PRN | Nausea / vomiting |
Pain — Mild
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Acetaminophen | 650 mg PO Q6H PRN | Mild pain / headache |
Pain — Moderate (select ONE)
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Oxycodone IR | 5 mg PO Q4H PRN × 7 d | |
| Acetaminophen-oxycodone 325/5 | 1 tab PO Q4H PRN × 7 d | Watch APAP ceiling |
| Tramadol | 50 mg PO Q6H PRN × 7 d | Caution: ↓ seizure threshold — avoid in seizure-prone post-craniotomy |
Pain — Severe (select ONE)
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Oxycodone IR | 10 mg PO Q4H PRN × 7 d | |
| Acetaminophen-oxycodone 325/5 | 2 tabs PO Q6H PRN × 7 d |
Antihypertensives
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Labetalol | 10 mg IV push Q15min PRN | SBP >goal; hold HR <55 / bronchospasm |
| Hydralazine | 10 mg IV push Q4H PRN | Give if SBP not at goal after 2 doses labetalol |
| Nicardipine drip | 0.2 mg/mL, start 5 mg/hr, max 15 mg/hr | Titrate by 1–2.5 mg/hr Q10–15 min |
GI Prophylaxis / Bowel Regimen
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Famotidine | 20 mg IV push BID | Stress ulcer ppx if indicated |
| Pantoprazole | 40 mg IV daily | Alternative |
| Docusate | 100 mg PO BID | Hold for loose stools |
| Senna | 8.6 mg PO QHS | Hold for loose stools |
| Bisacodyl | 10 mg PR daily PRN | Constipation rescue |
Other
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Dexamethasone | 4 mg IV QID | Tumor / vasogenic edema; taper per plan |
| Insulin SC sliding scale | — | Glucose management |
| SCIP Neurosurgery Post-Op Antibiotics | +1 min | See subphase below |
Perioperative Antibiotic Prophylaxis Logic
- MRSA risk: prior MRSA, chronic wound care, dialysis, transfer from inpatient stay >3 d
- High SSI risk: obesity, malnutrition, CSF leak, EVD, spinal instrumentation, age >60, open posterior approach, OR time >2–4 h, prior shunt infection, emergent case, ASA ≥2, DM
| Scenario | Typical prophylaxis concept | Student pearl |
|---|---|---|
| Low SSI risk, no major allergy | Cefazolin is the usual first-line concept for elective craniotomy, CSF shunting, and many implant procedures; dosing is weight-based. | Do not anchor on a fixed adult dose. Timing and redosing are as important as agent choice. |
| Severe beta-lactam allergy | Clindamycin or vancomycin-type alternatives may be used depending on local guidance and organism risk. | Clarify the allergy phenotype; many “penicillin allergies” are not true contraindications to cefazolin. |
| MRSA risk | Vancomycin may be added or substituted when MRSA risk is meaningful; start early enough for infusion before incision. | Vancomycin is not a casual add-on. It changes timing, stewardship, and nephrotoxicity considerations. |
| High SSI / gram-negative risk | Broader coverage is a surgeon/pharmacy/infectious-disease decision guided by procedure type, local microbiology, and patient risk. | A student should ask why coverage is broader, not memorize a fixed ceftriaxone or fluoroquinolone default. |
Post-Op Imaging & Labs
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| XR Chest 1 View | Today, portable | Follow-up opacities / line check |
| XR Shuntogram | Urgent, portable | VP shunt cases |
| CT Brain w/o contrast | STAT | Routine post-op brain |
| MRI Brain w/o contrast | Urgent | Tumor — known mass s/p surgery |
| MRI Brain w/ + w/o contrast | Urgent | Preferred for tumor extent of resection |
| BMP | AM Lab | Default daily |
| CBC w/ diff | AM Lab | |
| CMP, Mg, Phos, Prealbumin, PT/INR, aPTT | T+1;0200, AM Lab | Add as clinically indicated |
Respiratory & Consults
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Oxygen therapy | Nasal cannula 2 L | Titrate to SpO₂ >92% |
| Bedside Swallow Eval | EDD tomorrow | If dysphagia screen FAILED |
| OT Eval & Treatment | Routine | |
| PT Eval & Treatment | Routine | |
| Social Work / Case Management | — | Disposition planning |
2. ICU Admission
Generic critical care admission shell — overlay specialty subphase (Neuro ICU, post-op, etc.).
Admit / Code Status / Prophylaxis
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Full Resuscitation | Constant | Default unless DNAR |
| DNAR | — | Select order sentence if applicable |
| Present on Admission (POA) | — | Documentation flag |
| VTE Prophylaxis | — | Mechanical + pharmacologic per risk |
Patient Care / Monitoring
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Vital Signs | Routine | ICU continuous + Q1H documentation |
| Neuro Checks | Q2H | Neuro ICU patients |
| Spine Checks | Q1H | Spinal cord injury / post-spine |
| Vital Sign Parameters | MAP >65 | Customize per pathology |
| Urinary Catheter | Indwelling | Strict I&O |
| Intake & Output | Q2H | |
| Arterial Line Pressure | Q1H | Continuous monitoring |
| Hemodynamic Monitoring | Q1H | |
| Central Venous Pressure | Q4H | |
| Enteral Tube | NG, suction (gravity) | |
| Tobacco Treatment Counseling | — | Use when relevant to admission and discharge planning |
| Rapid Response / Critical Care Team Activation | Constant | Use local escalation pathway for deterioration |
Vasoactive Drips
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Norepinephrine 16 mcg/mL | Start 5, max 20 mcg/min | Goal MAP; titrate Q5–15 min by 1–5 mcg/min. First-line vasopressor. |
| Epinephrine 20 mcg/mL | Start 2, max 10 mcg/min | Add for refractory shock / cardiogenic |
| Vasopressin 1 unit/mL | 0.04 units/min fixed | Adjunct to NE in septic shock |
| Phenylephrine 200 mcg/mL | Start 50, max 350 mcg/min | Pure α — useful in tachyarrhythmia |
Continuous IV Antihypertensives
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Nicardipine 0.2 mg/mL | Start 5, max 15 mg/hr | Preferred for SAH/ICH BP control |
| Esmolol 10 mg/mL | Start 50, max 300 mcg/kg/min | |
| Nitroglycerin 200 mcg/mL | Start 5, max 200 mcg/min | Goal SBP |
Stress Ulcer Prophylaxis — Indications
- Coagulopathy (PLT <50K, INR >1.5, or PTT >2× ULN)
- Mechanical ventilation
- Trauma — spinal cord injury or severe TBI
- Burn / thermal injury
- Steroid use (>250 mg hydrocortisone equivalent/day)
- Active PUD / GERD / pre-admission PPI
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Famotidine | 20 mg IV push BID | First-line |
| Pantoprazole | 40 mg IV daily | PPI alternative |
Bowel & Glucose
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Docusate | 100 mg via FT BID | |
| Senna | 8.8 mg via FT BID | |
| Bisacodyl | 10 mg PR daily PRN | Constipation |
| Insulin SC sliding scale | — | Glycemic control |
| Insulin (non-DKA continuous infusion) | — | If persistent hyperglycemia |
Labs
Labs Now (STAT): ABG, BMP, Ca, CBC w/ diff, CMP, CPK, D-dimer, fibrinogen, lactic acid, hepatic panel, Mg, aPTT, Phos, PT/INR, resuscitation panel arterial, troponin I.
Labs in AM (T+1;0200): Same panel + prealbumin.
Microbiology, Imaging & Cardiac
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Blood cultures × 2 | Q15min × 2 sites | BEFORE first abx dose |
| Urinalysis w/ reflex culture | Routine | |
| Respiratory culture | — | If pneumonia suspected |
| XR Chest 1 view | Urgent, portable | Dyspnea / line placement |
| XR NG tube verification | Today, portable | Confirm gastric placement |
| CT Brain w/o contrast | Urgent, portable | AMS / r/o bleed |
| CT Abd/Pelvis w/ PO + IV contrast | STAT | Abdominal pain |
| EKG 12-lead | Routine, ONCE | |
| EKG series × 3 | STAT → +6 hr → +12 hr | Serial troponin / dysrhythmia rule-out |
Respiratory, Therapies & Consults
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Incentive Spirometry | Routine | |
| Oxygen therapy | NC 2 L | Titrate SpO₂ >92% |
| PT / OT / SLP eval | — | Early mobilization |
| Social Work / Case Management | — | |
| Nutrition consult | — | |
| Wound care (enterostomal) | — | |
| Palliative Care | — | Goals-of-care conversations |
3. TBI / Intermediate Head Injury
Step-down or floor-level TBI orders. Escalate to Neuro ICU subphase if GCS deteriorates, ICP monitoring needed, or hemodynamic instability.
Patient Care
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Vital Signs | Q2H | Routine |
| Neuro Checks | Q2H | ↑ frequency to Q1H if GCS change |
| Nurse Communication | — | Do NOT remove c-collar until c-spine cleared by team |
| Notify Provider | — | Signs/symptoms of neurologic decompensation |
| Pneumatic Compression Device (SCDs) | Below knee, bilateral, BID | Mechanical VTE ppx |
| Intake & Output | Q4H | |
| VTE Prophylaxis | — | Pharmacologic — see A&P note |
| Care Plan: Cerebral Perfusion Risk | — | Use when neurologic monitoring and escalation triggers need to be explicit |
Weight Bearing Status
Order per affected extremity (LUE/RUE/LLE/RLE):
- Non-weight bearing
- Partial weight bearing
- Toe-touch weight bearing (LE only)
- Weight bearing as tolerated (WBAT)
Activity / Positioning
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Activity | Out of bed with assistance | Constant order |
| Position Patient | HOB ≥30° | Cerebral venous drainage |
| Turn & Reposition | Q2H | While in bed |
Diet / IV Fluids
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| NPO | — | Until dysphagia screen passed |
| Diet | Regular, regular consistency | Modified by nutrition alert if applicable |
| 0.9% NaCl | 1,000 mL IV @ 80 mL/hr | Isotonic — AVOID hypotonic in TBI |
| 0.9% NaCl + KCl 20 mEq/L | 1,000 mL IV @ 100 mL/hr | |
| Isolyte S pH 7.4 bolus | 500 mL IV bolus ONCE | Balanced crystalloid |
Seizure Prophylaxis (Levetiracetam)
Early post-traumatic seizure prophylaxis is commonly considered for severe TBI during the first 7 days. Brain Trauma Foundation guidance does not establish levetiracetam as superior to phenytoin, so agent and dose should follow local neurotrauma practice.
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Levetiracetam IV/PO/FT | Institution-specific, often BID | Commonly used because it is easy to administer and has fewer interactions; adjust for renal function and patient factors. |
| Alternative antiseizure agent | Per neurotrauma / epilepsy team | Phenytoin/fosphenytoin or other agents may be selected depending on indication, interactions, and monitoring needs. |
| Stop date / reassessment | Usually day 7 if prophylaxis only | Continuing beyond 7 days should have a documented reason, such as seizure, cortical irritation concern, or epilepsy history. |
Analgesia
Antipyretic / Mild Pain
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Acetaminophen | 650 mg via FT Q4H PRN | Fever T >38.4 °C |
| Acetaminophen | 650 mg via FT Q4H PRN | Mild pain / headache |
Pain — Moderate (select ONE)
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Oxycodone IR | 5 mg liquid via FT Q4H PRN × 7 d | |
| Morphine | 2 mg IV Q4H PRN × 7 d | |
| Hydromorphone | 0.2 mg IV Q4H PRN × 7 d |
Pain — Severe (select ONE)
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Oxycodone IR | 10 mg liquid via FT Q4H PRN × 7 d | |
| Morphine | 4 mg IV Q4H PRN × 7 d | |
| Hydromorphone | 0.5 mg IV Q4H PRN × 7 d | |
| Fentanyl | 25 mcg IV Q4H PRN × 7 d | Hemodynamically neutral |
| Fentanyl (rescue) | 50 mcg IV push Q2H PRN | If no oral access or inadequate response |
GI Prophylaxis & Bowel Regimen
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Famotidine | Institution-specific | Stress ulcer prophylaxis if severe TBI/ICU risk factor is present |
| Pantoprazole | Institution-specific | Alternative when PPI is specifically indicated |
| Docusate | 100 mg PO BID | Hold for loose stools |
| Senna | 8.6 mg PO QHS | Hold for loose stools |
| Bisacodyl | 10 mg PR every other day PRN | Constipation |
Antiemetic / Antihypertensive
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Ondansetron | 4 mg IV push Q6H PRN | N/V |
| Hydralazine | 10 mg IV push Q6H PRN | SBP >goal; give over 2 min |
| Labetalol | 10 mg IV push Q15min PRN | SBP above goal; give over 2 min |
Labs & Imaging
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| CBC w/ diff | AM Lab | |
| BMP | AM Lab | Default daily |
| CMP, Mg, Phos, Prealbumin, PT/INR, aPTT | T+1;0200, AM Lab | Add per indication |
| CT Brain w/o contrast | Urgent — cerebral hemorrhage suspected | Repeat for exam change / per protocol |
Consults
| Component | Dose / Route / Freq | Details / Notes |
|---|---|---|
| Occupational Therapy Eval & Treatment | Routine | |
| Physical Therapy Eval & Treatment | Routine | |
| Neuropsychology consult | — | Cognitive baseline |
| Speech-Language Pathology | — | Dysphagia / cognitive-linguistic |
| Social Work / Case Management | — | |
| Health Care Proxy Designation | — | Medico-legal |
4. Quick A&P Template — TBI / Intermediate Head Injury
Educational structure for how a TBI/head-injury plan is commonly organized. Adapt to the patient, service preferences, and supervising resident/attending.
- Q4H neuro checks
- Blood pressure goal per neurosurgery team, commonly SBP <140 after cranial surgery/head injury
- Seizure prophylaxis if indicated, with dose adjusted to patient factors
- Antibiotics only if prophylaxis window or infection indication applies
- PT / OT
- DVT prophylaxis: SCDs ± pharmacologic prophylaxis per team and imaging stability
- Keep HOB > 30°
- Diet: Regular (pending dysphagia screen)
- Code status: Full
What is SCIP?
SCIP = Surgical Care Improvement Project — a CMS / Joint Commission national quality initiative (launched 2006) aimed at reducing surgical complications, especially SSIs, VTE, and perioperative cardiac events.
Antibiotic prophylaxis measures
- Prophylactic abx given within 1 hour before incision (2 hours for vanc / fluoroquinolones)
- Correct agent selected for the procedure
- Prophylactic antibiotics discontinued within 24 hours of anesthesia-end time for most procedures unless there is documented infection or a procedure-specific reason to extend.
Other historical SCIP measures
- Hair removal with clippers, not razors
- Perioperative normothermia
- Perioperative glucose control (cardiac surgery)
- Beta-blocker continuation
- VTE prophylaxis ordered + given within 24 h of surgery
5. Neuromodulation Program — DBS, SCS, Pumps & Hardware
This section is designed for students learning what to anticipate before and after common functional neurosurgery cases. The goal is not to memorize an order set; it is to understand the handoff logic, device-specific hazards, and the questions that should be asked before the patient leaves the perioperative area.
Pre-Operative STN DBS Checklist
| Checklist item | Typical student-facing wording | Why it matters |
|---|---|---|
| NPO / diet | NPO at midnight; morning medications only if specifically allowed with a sip of water. | Standard anesthesia safety while preserving critical medications when approved. |
| Parkinson medications | Order home Parkinson medications, but hold dopaminergic medications after midnight for awake STN DBS unless the team says otherwise. | Patients are often intentionally tested in the OFF-medication state for targeting and stimulation assessment. |
| Morning PD dose | Have the patient bring the morning Parkinson medication dose to the perioperative area in a labeled bag, but do not take it pre-op unless instructed. | Medication may be needed immediately after lead placement or if the plan changes. |
| Blood pressure medications | Continue approved BP medications the morning of surgery with a sip of water. | Hypertension during lead placement increases hemorrhage concern; hypotension also impairs testing. |
| Antiplatelets / anticoagulants | Confirm aspirin, antiplatelets, anticoagulants, and supplements have been held per protocol. | Lead-pass hemorrhage is a catastrophic complication; this is a pre-op timeout item. |
| Skin prep | Chlorhexidine shampoo/wash the night before or morning of surgery if part of local workflow. | Hardware procedures are infection-sensitive. |
| MRI workflow | If pre-op stereotactic MRI is planned, send the patient to MRI rather than directly to the OR; avoid IV pumps or non-compatible equipment in the MRI pathway. | The morning workflow may depend on imaging before frame/lead placement. |
| MRI-compatible gown | Confirm gown and transport equipment do not contain metallic clips or MRI-incompatible hardware. | Small workflow misses can delay the case or create MRI safety risk. |
| Antibiotic plan | Check allergy status and confirm peri-incision antibiotic selection with anesthesia/nursing. | Antibiotics must match allergy/MRSA risk and be timed before incision. |
| Baseline exam | Document tremor, rigidity, speech, gait baseline, and last dopaminergic dose time. | Baseline symptoms guide intraoperative testing and post-op interpretation. |
Post-Operative STN DBS Checklist
| Checklist item | Common pattern | Why it matters |
|---|---|---|
| Diet | Sips, then diet as tolerated after swallow/nausea assessment. | Many patients are older, sedated, or nauseated after frame-based surgery. |
| Vitals / neuro checks | Frequent early checks, often Q1H for several hours, then space if stable. | Early hemorrhage, seizure, confusion, or lead-related deficits must be caught quickly. |
| Home medications | Restart regular medications; Parkinson medications usually resume on the pre-op schedule unless the functional team changes it. | Avoid dopamine-withdrawal syndromes and severe OFF-state immobility. |
| Antibiotics | Perioperative cefazolin or alternative by allergy/MRSA risk, typically limited to 24 hours unless infection is suspected. | Hardware infection prevention without unnecessary prolonged prophylaxis. |
| Post-op CT | Noncontrast CT head with stereotactic/lead-localization protocol as requested by the surgeon. | Assesses hemorrhage, pneumocephalus, and electrode location. |
| Wound care | Keep cranial wounds covered and dry; reinforce but do not remove dressings unless instructed. | Reduces contamination and avoids disturbing fresh incisions. |
| Discharge teaching | Keep wounds dry for about 10 days, no strenuous activity for about 6 weeks, call for fever, drainage, wound redness, new neurologic deficit, or severe headache. | Simple discharge rules catch the main early complications. |
| Programming follow-up | Return to DBS clinic for initial stimulation programming, commonly around 4-6 weeks depending on local practice. | Leads are usually implanted before the system is optimized therapeutically. |
Post-Operative Functional Craniotomy / Epilepsy Resection Checklist
| Checklist item | Common pattern | Why it matters |
|---|---|---|
| Diet / activity | Sips then diet as tolerated after swallow/nausea assessment; activity as tolerated when cleared. | Early mobility helps recovery, but sedation, seizures, neglect, weakness, or visual field deficits can create fall risk. |
| Vitals / neuro checks | Frequent checks early, then space if stable. | Watch for hemorrhage, edema, seizure, aphasia, weakness, visual field cut, neglect, or mental-status change. |
| Seizure plan | Continue home antiseizure medications; confirm peri-op loading, rescue medication, and when to call neurology/epilepsy. | Medication omission is a common and preventable post-op seizure trigger. |
| Steroid / edema plan | Dexamethasone taper only if indicated by surgeon/pathology/edema risk; pair with glucose and GI-risk awareness. | Dominant temporal/frontal resections and tumor-adjacent epilepsy cases may have edema-related deficits. |
| Lines / Foley / compression | Remove arterial line, Foley, and calf compressors once mobilizing and clinically appropriate. | Reduces line/catheter complications while preserving early safety. |
| Morning labs | CBC and electrolytes as directed; sodium is especially relevant if there is DI/SIADH risk or major sellar/hypothalamic involvement. | Checks blood loss and physiology; electrolyte shifts can worsen seizures or mental status. |
| Blood pressure | Maintain surgeon-specified SBP goal, commonly below 140; labetalol/hydralazine/nicardipine are typical tools. | Post-craniotomy hypertension increases bleeding risk, while over-treatment can impair cerebral perfusion. |
| Pain / nausea | Acetaminophen-first, low-dose opioids PRN, ondansetron or similar antiemetic per local medication guidance. | Excess sedation can obscure the neurologic exam and complicate seizure monitoring. |
| Wound / dressing | Keep cranial wound covered and dry; reinforce but do not remove dressings unless instructed. | Protects incision and helps patients recognize abnormal drainage. |
| Discharge teaching | Keep wound dry as instructed, remove sutures/staples per plan, no strenuous activity for about 6 weeks, and follow seizure/driving restrictions. | Students should explicitly know the red flags: fever, drainage, severe headache, new deficit, seizure cluster, or confusion. |
SCS Trial / Permanent Implant Checklist
| Checklist item | Common pattern | Why it matters |
|---|---|---|
| Pre-op anticoagulation review | Confirm anticoagulants, antiplatelets, and NSAIDs were held according to neuraxial/device policy. | Epidural hematoma is rare but devastating. |
| Antibiotics | Cefazolin or alternative based on allergy/MRSA risk before incision; duration per local device policy. | Implanted pulse generators and leads are infection-sensitive. |
| Trial lead precautions | Keep dressing dry/intact; avoid bending, twisting, lifting, or lead-tension movements. | Lead migration can ruin trial interpretability. |
| Paddle lead precautions | Focused lower-extremity motor/sensory exam, wound checks, log-roll or spine precautions if directed. | Early neurologic change after laminotomy needs immediate attention. |
| Device representative | Confirm interrogation/programming and documentation before discharge. | A technically successful implant still needs functional programming. |
| Discharge restrictions | No driving while on opioids or until cleared; avoid strenuous bending/twisting/lifting during early healing. | Protects lead position and wound closure. |
IPG / Battery Change Checklist
| Checklist item | Common pattern | Why it matters |
|---|---|---|
| Device identity | Confirm device type, laterality, generator location, baseline settings, and reason for replacement. | Wrong-device or wrong-side errors are preventable with a deliberate timeout. |
| Antibiotic / allergy check | Confirm prophylaxis and allergy/MRSA status. | Generator pockets can seed the whole system. |
| Anticoagulation plan | Confirm peri-op hold/resume timing with surgeon and prescribing clinician. | Pocket hematoma increases pain, reoperation, and infection risk. |
| Post-exchange interrogation | Document impedance check, settings restored/updated, patient controller paired, and charging instructions if rechargeable. | The case is not complete until therapy is confirmed. |
| Wound teaching | Keep incision dry, avoid pressure over pocket, call for redness, drainage, fever, swelling, or sudden loss of benefit. | Pocket infection and lead/system malfunction often present after discharge. |
Intrathecal Baclofen Pump Emergencies
| Scenario | Clues | Initial management priorities |
|---|---|---|
| Withdrawal / underdose | Return of baseline spasticity, pruritus, paresthesias, hypotension, fever, altered mental status; severe cases can progress to rigidity, rhabdomyolysis, organ failure, and a sepsis/malignant-hyperthermia-like picture. | ABCs, ICU-level monitoring, urgent pump interrogation/refill status/catheter evaluation, contact the treating pump clinician. Restore intrathecal baclofen delivery when possible. Oral/enteral baclofen and IV benzodiazepines may be used as bridge therapy, but oral baclofen alone should not be relied on for severe withdrawal. |
| Overdose | Drowsiness, dizziness, somnolence, hypotonia, respiratory depression, hypothermia, seizures, loss of consciousness, coma. | ABCs, airway/ventilatory support as needed, urgent pump specialist involvement. The pump reservoir may need to be emptied/stopped by trained personnel; CSF aspiration is a specialist procedure in selected severe cases. |
| Common triggers | Empty reservoir, missed refill, programming error, pump alarm, catheter kink/disconnection, pocket fill, infection, recent refill or concentration change. | Ask: When was the last refill? What is the current concentration/daily dose? Any pump alarms? Any recent MRI? Any trauma or new wound problem? |
Neuromodulation Hardware Infection — First Steps
| Situation | What to look for | First-step mindset |
|---|---|---|
| Superficial cellulitis concern | Localized erythema, tenderness, warmth, drainage absent or minimal, no exposed hardware, patient clinically stable. | Photograph/mark borders, notify implanting team, check vitals and labs as directed. Antibiotics may be appropriate, but avoid delaying surgical evaluation. |
| Deep pocket/lead infection concern | Purulence, wound dehiscence, fluctuance, exposed hardware, erosion, fever, bacteremia, severe pocket pain, recurrent drainage. | Escalate urgently. Obtain cultures when feasible before antibiotics if stable; if septic or unstable, treat immediately. Deep or exposed hardware often requires washout and partial or complete explantation plus antibiotics. |
| DBS-specific hazard | Scalp erosion or lead exposure may seed intracranial hardware even if the patient looks well. | Do not dismiss a small scalp opening. Keep covered, avoid manipulation, and contact functional neurosurgery promptly. |
| SCS / pump-specific hazard | Generator or pump pocket infection can track along tunneled leads/catheters. | Assess the entire hardware path, not just the painful pocket. |
6. Anesthesia Considerations — Neuromodulation & Functional Cases
Pre-op huddle prompts and agent considerations for DBS, SCS, intrathecal pump, RFA/rhizotomy, and VNS. Built around what actually affects intraoperative neurophysiology and surgical conditions — not generic GA checklists.
DBS — Awake with Microelectrode Recording (MER)
The most anesthesia-sensitive functional case. Almost every common sedative degrades MER signal quality and the clinical exam.
Agents — what to use and what to avoid
| Agent | Use? | Why |
|---|---|---|
| Dexmedetomidine | ✓ Preferred sedative | Preserves STN/GPi firing patterns at low doses. Keep ≤0.3–0.5 mcg/kg/hr during MER. Higher doses still degrade burst patterns and can blunt tremor. |
| Remifentanil | ✓ Low-dose infusion OK | For pin placement and incision. Short context-sensitive half-time allows rapid wake-up for testing. Watch respiratory depression in elderly PD. |
| Propofol | ✗ STOP ≥20 min before MER | Suppresses STN bursting pattern even at sub-sedative doses. Acceptable for burr hole drilling if fully off before recording starts. |
| Benzodiazepines | ✗ Avoid entirely | Suppress STN neuronal firing for hours. Long half-life makes intraop testing unreliable. No pre-op midazolam. |
| Volatile agents | ✗ Not applicable (awake) | — |
| Neuromuscular blockade | ✗ Never | Need to assess rigidity, tremor, and stimulation-induced motor effects. |
| Local anesthetic | ✓ Generous | Pin site infiltration + scalp block (supraorbital, supratrochlear, auriculotemporal, greater/lesser occipital). This is where patient comfort is won or lost. |
Hemodynamics
- SBP target <140 mmHg from skin incision through final lead placement — every 10 mmHg above baseline increases ICH risk along the lead track.
- Treat hypertension early and aggressively. Have labetalol and nicardipine drip drawn up before incision.
- Avoid hypotension too — cerebral hypoperfusion in elderly PD patients triggers confusion that ruins testing.
- Vasopressor preference: phenylephrine bolus over ephedrine (avoid tachycardia and tremor exacerbation in PD).
Patient prep
- Hold PD meds 12 h pre-op for STN targeting — need patient in OFF state for tremor/rigidity assessment. Confirm with movement disorders neurologist.
- Hold anticoagulants/antiplatelets per standard cranial protocol (ASA 7 d, clopidogrel 7 d, warfarin INR <1.3, DOACs 48–72 h).
- Foley placed after frame on, before draping — long case + dex diuresis = full bladder = ruined exam.
- Position: semi-sitting with frame fixed to table. VAE risk — precordial Doppler if available, T-piece on CVL, vigilant ETCO₂ monitoring.
- Temperature: warming blanket on lower body only, avoid covering arms (need to see tremor).
- Skip N₂O if any pneumocephalus expected.
DBS — Asleep (Image-Guided, No MER)
iCT or iMRI verification, no intraop testing. Anesthetic flexibility is much greater.
- Standard GA acceptable — TIVA or volatile.
- Same SBP <140 target during lead pass.
- NMB acceptable since no motor testing.
- If doing macrostimulation testing under light anesthesia: switch to TIVA + dex 30 min before testing window, hold NMB, communicate the "test window" timeline to anesthesia.
- Pre-op PD meds can be continued (no exam needed) — confirm with movement disorders.
DBS — Asleep with MER (rare hybrid)
- TIVA preferred: low-dose propofol (≤75 mcg/kg/min) + remifentanil + dex (≤0.3 mcg/kg/hr).
- If volatile is unavoidable, keep sevoflurane <0.3 MAC (some centers tolerate up to 0.5 MAC but recording quality drops measurably above 0.3). Desflurane and isoflurane suppress MER more than sevo at equivalent MAC — avoid if possible.
- NMB only for intubation, then allow full reversal before recording.
- Recognize MER quality will be inferior to awake — adjust expectations and physiology mapping interpretation accordingly.
SCS — Trial (Percutaneous)
- Local + light MAC: fentanyl 25–50 mcg, ± versed 1–2 mg titrated.
- Patient must be responsive for paresthesia mapping — they need to report coverage of pain area as leads are advanced.
- No NMB. No deep sedation.
- Prone positioning — confirm airway access plan with anesthesia.
SCS — Permanent Paddle Lead (Laminotomy)
- GA with IONM — SSEPs and EMG to confirm midline placement and avoid cord injury.
- TIVA preferred (propofol + remifentanil ± low-dose ketamine) for stable SSEP signals. Volatile agents >0.5 MAC degrade SSEPs.
- NMB ONLY for intubation — full reversal required before stimulation testing or EMG monitoring.
- Confirm IONM tech is booked in pre-op huddle. Most common reason cases get delayed.
- Some surgeons wake patient briefly intraop for paresthesia confirmation — flag this to anesthesia in advance so they plan emergence.
Intrathecal Drug Delivery (Pump Implant / Revision)
- GA or spinal acceptable — spinal often preferred to avoid post-op nausea and allow dose titration awake.
- If intraop test bolus given: respiratory monitoring × 24 h post-op (capnography preferred), naloxone at bedside.
- Watch for CSF leak intraop — communicate to anesthesia for positioning and post-op flat bed orders.
- Avoid IM opioids post-op — confounds intrathecal dose assessment.
Percutaneous Rhizotomy / RFA for Trigeminal Neuralgia
- MAC with deep boluses for the noxious portions (foramen ovale cannulation, lesioning) and rapid emergence for sensory testing.
- Typical pattern: propofol bolus 30–50 mg for cannulation → wake for sensory mapping → bolus for thermocoagulation → wake for re-test.
- Anesthesia must be comfortable with repeated deep-light cycling. Discuss timing in pre-op huddle.
- Watch for trigeminocardiac reflex — bradycardia/asystole on cannulation. Glycopyrrolate pre-treatment, atropine drawn up.
- Airway: nasal cannula with ETCO₂, no NMB, no LMA (interferes with V3 access).
SRS (Gamma Knife / LINAC) — Sedation for Frame Placement
- Local anesthetic infiltration at pin sites is the workhorse — generous lidocaine + bupivacaine mix.
- Light sedation only: fentanyl 25–50 mcg ± midazolam 1 mg. Patient must protect airway and cooperate.
- Anxiolysis is the main need — many patients tolerate frame placement with versed alone.
- For pediatric or claustrophobic adults: consider GA with LMA for the imaging/treatment portion (rare in adult practice).
VNS Implant
- Standard GA, neck extension positioning.
- No NMB after intubation if intraop device interrogation/lead test planned (need to see vocal cord/diaphragm response).
- Watch for bradycardia/asystole during initial lead test — atropine drawn up, communicate test timing to anesthesia.
Pre-Op Huddle — Questions to Ask Anesthesia
For every case
- What's our BP target during the critical phase, and what agents do you have ready to treat HTN?
- What's the planned vasopressor of choice if hypotension occurs? Phenylephrine is often useful in PD/elderly patients because it avoids tachycardia and tremor exacerbation.
- Are anticoagulants and antiplatelets confirmed held per protocol?
- Are we avoiding N₂O?
- What's the post-op disposition — ICU, step-down, or PACU-to-floor?
DBS with MER
- What's your TIVA recipe for the MER window? Confirm: no propofol within 20 min of recording, no benzos at all, dex ≤0.5 mcg/kg/hr.
- Are PD meds confirmed held since last night?
- Scalp block plan — supraorbital, supratrochlear, auriculotemporal, occipital. Want me to do it or you?
- VAE monitoring — precordial Doppler available? CVL aspiration plan?
- Foley before drape?
- What's the plan if patient becomes uncooperative or panicky mid-case? (Convert to dex bolus, abort and switch to asleep, etc.)
SCS paddle / spinal IONM cases
- IONM tech confirmed and in room?
- TIVA with propofol + remi, volatile <0.5 MAC?
- NMB fully reversed before SSEP baseline?
- Are we planning a brief wake-up for paresthesia mapping?
RFA / Rhizotomy
- Comfortable with deep-light cycling for cannulation → testing → lesioning → testing?
- Glycopyrrolate given? Atropine drawn up for trigeminocardiac reflex?
- ETCO₂ via nasal cannula in place?
Pump / intrathecal
- Test bolus planned — respiratory monitoring orders for 24 h post-op confirmed?
- Naloxone at bedside in PACU and floor?
Quick Drug Reference — Functional OR
| Drug | Typical Use | Pearls |
|---|---|---|
| Dexmedetomidine | 0.2–0.5 mcg/kg/hr (no bolus) | Sedative of choice for awake DBS. Bolus causes hypertension then hypotension — skip the load. |
| Remifentanil | 0.02–0.05 mcg/kg/min | For incision/pin pain. Off 5 min before testing window. |
| Propofol | 25–75 mcg/kg/min TIVA | Off ≥20 min before MER. OK for asleep cases. |
| Phenylephrine | 50–100 mcg IV bolus PRN | First-line pressor in awake DBS. |
| Labetalol | 5–10 mg IV PRN | HTN control during lead pass. |
| Nicardipine drip | 2.5–15 mg/hr | Sustained HTN control. |
| Glycopyrrolate | 0.2 mg IV pre-op | Prophylaxis for trigeminocardiac reflex in rhizotomy. |
| Atropine | 0.5–1 mg IV bolus | Drawn up for VNS lead test and rhizotomy. Treat bradycardia/asystole. |
7. Safety Defaults and Teaching Pearls
General Safety Principles
- High-frequency, low-risk items are usually easy to anticipate: vitals, neuro checks, SCDs, HOB ≥30°, acetaminophen, ondansetron, and bowel regimen.
- High-risk items should always trigger deliberate review: opioids, anticoagulants, steroids, antibiotics, insulin, pressors, and sedatives.
- Pain ladders should avoid duplicate opioid pathways; students should notice when more than one PRN opioid could be given for the same pain score.
- Seizure prophylaxis, antibiotic prophylaxis, and stress-ulcer prophylaxis are best understood as indication-based decisions, not automatic medications.
- Age, frailty, weight, renal function, hepatic function, and baseline cognition should change how medication defaults are interpreted.
Functional / Pain Neuromodulation Pearls
- DBS Post-Op Day 0: frequent early vitals/neuro checks, no anticoagulation until cleared, prompt post-op CT or MRI per surgeon/device protocol, BP goal defined by the team, and a deliberate plan for restarting dopaminergic medications.
- SCS Trial / Permanent Implant: peri-incision antibiotics by local prophylaxis guidance, neuraxial anticoagulation precautions, focused lower-extremity motor/sensory exam, wound check, activity restrictions, and device interrogation/programming before discharge.
- Intrathecal Pump: bowel/bladder check, respiratory monitoring when intrathecal opioid dosing is involved, naloxone availability when appropriate, pump interrogation, and explicit withdrawal/overdose return precautions.
Radiosurgery-Specific Pearls
- GK / LINAC SRS day-of: steroid, antiemetic, and anxiolytic plans are indication-specific; frame-pin care if a Leksell frame is used; post-procedure observation and neuro checks per local discharge criteria.
- Post-SRS for trigeminal neuralgia: continue current neuropathic regimen, document baseline BNI pain score, schedule 3-month follow-up with imaging.
Safety Defaults Worth Remembering
- Default mechanical VTE ppx (SCDs) on every neuro admission; require active opt-out with reason.
- Default "Notify provider for UOP >250 mL/hr × 3 hrs" on every cranial post-op (DI surveillance).
- Default "Notify provider for any GCS drop ≥2 points or new focal deficit" on all neuro admissions.
- Default isotonic fluids only (NS or LR) on TBI/SAH/post-craniotomy sets — block hypotonic at order-entry.
- Hyperosmolar therapy should be treated as an escalation pathway, not a routine floor order: central-line requirements, sodium/osmolality monitoring, renal status, and ICU-level oversight matter.
Documentation Habits
- Document the neurologic baseline clearly before sedating medications, transfer, or discharge.
- For device cases, document device type, laterality, target/lead level, generator site, interrogation status, and any programming changes.
- For ICU patients, document the reason for ICU-level care, neurologic monitoring frequency, BP/MAP goals, airway status, and escalation triggers.
- For SRS-related peri-procedure care, document baseline cranial nerve/pain score when relevant, steroid plan, frame or mask details, and follow-up imaging plan.
Selected Online Resources & Source Links
These links are intended as starting points for students who want to understand the source logic behind the checklist. For patient care, use local protocols and supervising-team guidance.
| Resource | Best use | Link |
|---|---|---|
| NACC infection prevention and management | Neuromodulation hardware infection prevention, antibiotic logic, and management framework. | PubMed: NACC infection recommendations |
| NACC bleeding and coagulation | Anticoagulation/antiplatelet decision-making for neuromodulation procedures. | PubMed: NACC bleeding/coagulation recommendations |
| NACC cervical neurostimulation | Best-practice framework for higher-risk cervical SCS/DRG-style anatomy. | PubMed: NACC cervical neurostimulation |
| SCS patient selection and trial stimulation consensus | How to think about SCS candidacy, trialing, psychosocial screening, and expected benefit. | PMC full text: SCS selection/trial consensus |
| ASRA antithrombotic guidelines | Neuraxial/regional anesthesia anticoagulation framework; useful when thinking about SCS and epidural access. | ASRA fifth edition guideline |
| Brain Trauma Foundation severe TBI guidelines | Seizure prophylaxis, VTE prophylaxis, ICP/CPP, hyperosmolar therapy, and severe TBI ICU principles. | Brain Trauma Foundation guidelines |
| ASHP/IDSA/SIS/SHEA surgical antimicrobial prophylaxis | Agent selection, timing, weight-based dosing, and redosing principles for surgical prophylaxis. | IDSA guideline page |
| Intrathecal baclofen withdrawal safety information | Recognition of baclofen underdose/withdrawal and why urgent pump-specialist escalation matters. | Lioresal withdrawal safety page |
| Intrathecal baclofen emergency procedures | FDA-label emergency framework for overdose and withdrawal/underdose. | FDA label / refill kit PDF |
| DBS overview for patients | Patient-facing overview of DBS indications, risks, and workflow. | AANS DBS overview |
| DBS hardware infection outcomes | Clinical outcomes by management strategy: medical therapy, retention, partial removal, or complete explantation. | DBS infection management experience |